Clinical Reasoning: A 22-Year-Old Man With Multifocal Brain and Osseous Lesions.
Sumanth P ReddySara C LaHueSoonmee ChaPublished in: Neurology (2023)
The evaluation of patients with disseminated processes with central nervous system and osseous involvement is often challenging. A 22-year-old healthy man developed left-sided weakness, paresthesias, and neck pain over several weeks. On clinical exam he was noted to have decreased right eye visual acuity, left-sided pyramidal weakness and numbness, and bilateral hyperreflexia. Magnetic resonance imaging (MRI) revealed multifocal widespread abnormalities: nonenhancing lesions throughout the infratentorial brain, pituitary gland, right frontal lobe, and optic nerves, in addition to an enhancing intramedullary cervical spinal cord lesion, extensive nodular leptomeningeal enhancement of the spine, and numerous enhancing bony lesions throughout the vertebrae and iliac bones. Cerebrospinal fluid (CSF) analysis was notable for normal opening pressure, protein 465 mg/dL, glucose 21 mg/dL, and normal cell count. Extensive serum and CSF analysis for infectious, inflammatory, and neoplastic etiologies was unrevealing, and the diagnosis was ultimately revealed after additional staining of tissue biopsy specimen from sacral and cerebellar biopsies. This case highlights the differential diagnoses for widely disseminated disease affecting the central nervous system and bones, and informs pediatric and adult clinicians of important recent developments regarding this diagnostic entity.
Keyphrases
- cerebrospinal fluid
- magnetic resonance imaging
- spinal cord
- single cell
- resting state
- functional connectivity
- white matter
- contrast enhanced
- oxidative stress
- blood pressure
- small cell lung cancer
- multiple sclerosis
- type diabetes
- metabolic syndrome
- adipose tissue
- small molecule
- mesenchymal stem cells
- case report
- magnetic resonance
- blood brain barrier
- diffusion weighted imaging
- skeletal muscle
- cerebral ischemia
- protein protein
- brain injury
- insulin resistance
- endovascular treatment
- preterm birth